As part of a donation of 4 million doses of COVAX by Switzerland, 24,000 doses of AstraZeneca vaccine were delivered to Sierra Leone. An additional 400,000 doses are to be delivered in the coming weeks.
Gavi CEO Dr. Seth Berkeley: “As our host since the inception of Gavi, Switzerland has strongly supported global vaccination – pledging funding to Gavi’s core budget as well as the Gavi COVAX Advance Market Commitment (Gavi COVAX AMC). This donation of 4 million doses strengthens Switzerland’s leadership in global health. “
Geneva, 11 October 2021 – The first shipment of 4 million doses donated by Switzerland arrived in Sierra Leone, with 24,000 doses of AstraZeneca vaccine landing in Freetown on October 9, 2021. More than 400,000 additional doses will be delivered to several countries in Africa and Asia in the coming weeks.
As host country for Gavi, Switzerland has long been a strong supporter of Gavi’s mission and vision. The Swiss federal government has increased its contribution to Gavi in recent years, pledging CHF 10 million for routine immunization programs in 2020 to help deliver life-saving vaccines to children around the world. Switzerland has also strengthened support for COVAX, pledging CHF 20 million in 2020 and an additional CHF 125 million in 2021 as part of Gavi COVAX AMC’s marketing commitments to help buy vaccines for people in low-income countries and territories. This recent donation of a dose is based on this support.
“As our host since the inception of Gavi, Switzerland has been a strong supporter of global vaccination – pledging funding to the Gavi core budget as well as the Gavi COVAX Advance Market Commitment (Gavi COVAX AMC),” said Gavi CEO Dr. Seth Berkeley … “This donation of 4 million doses strengthens Switzerland’s leadership in global health.”
These doses, donated by Switzerland, are produced by the AstraZeneca production network. A donation through COVAX helps increase vaccination coverage, ensures that the dose is not wasted, and helps end the acute phase of the pandemic. The development and implementation of the COVAX dose distribution mechanism is supported by a Canadian contribution of C $ 5 million.
Dose transfer via COVAX is possible through tripartite agreements between Gavi, manufacturers and donor countries. Country shipments will be handled by COVAX delivery partners UNICEF and the World Health Organization (WHO).
Hundreds of millions of doses have already been pledged to COVAX by a number of countries in response to short-term supply problems and new options. Working with donor governments to fulfill the growing number of dose-sharing commitments, COVAX expects more donor dose deliveries in the coming weeks and months.
Notes to editors
COVAX, the vaccine component in the COVID-19 Instrument Access Accelerator (ACT), is led by CEPI, Gavi and WHO, working in partnership with vaccine manufacturers in developed and developing countries, UNICEF, PAHO, the World Bank and others. It is the only global initiative working with governments and manufacturers to ensure that COVID-19 vaccines are available globally for both high-income and low-income countries.
Gavi’s role in COVAX
Gavi leads procurement and large-scale procurement for COVAX: the design and management of the COVAX Facility and the Gavi COVAX AMC, as well as working with its traditional partners in the Alliance, UNICEF and WHO, as well as governments on country readiness and delivery. As part of this role, Gavi hosts the COVAX Facility office to coordinate and operate the facility as a whole, maintains financial and legal relationships with 193 Facility members, and manages the COVAX Facility portfolio of deals: negotiating preliminary purchase agreements with promising candidate vaccine manufacturers to secure doses on behalf of all COVAX Facility participants. Gavi is also coordinating the development, deployment and fundraising for the Gavi COVAX AMC, a mechanism that provides access to donor-funded vaccine doses in 92 low-income countries. As part of this work, Gavi provides funding and oversight of UNICEF vaccine procurement and delivery to all AMC participants, enforcing pre-purchase agreements between Gavi and manufacturers, and supporting partners and governments in preparedness and delivery efforts. This includes individual support to governments, UNICEF, WHO and other partners for cold chain equipment, technical assistance, syringes, vehicles and other aspects of the highly complex logistics delivery operation. Gavi is also a co-author, fundraiser, and supports the implementation of AMC’s no-fault compensation mechanism, as well as the COVAX humanitarian buffer.
About Gavi, the Vaccine Alliance
Gavi, the Vaccine Alliance is a public-private partnership that helps vaccinate half of the world’s children against some of the world’s deadliest diseases. Since its inception in 2000, Gavi has helped immunize an entire generation – more than 888 million children – and prevented more than 15 million future deaths, helping to halve child mortality in 73 low-income countries. Gavi also plays a key role in improving global health security by supporting health systems as well as funding the global stockpile of Ebola, cholera, meningitis and yellow fever vaccines. After two decades of progress, Gavi is now focused on protecting the next generation and reaching the unvaccinated children who are still left behind, using innovative funding and cutting edge technologies – from drones to biometrics – to save millions more lives and prevent disease outbreaks before they happen. will spread. and help countries on their way to self-sufficiency. Find out more at www.gavi.org and connect with us on Facebook and Twitter…
Gavi is one of the organizers of COVAX, a vaccine component of the COVID-19 Access Accelerator (ACT), with the Coalition for Epidemic Preparedness Innovation (CEPI) and the World Health Organization (WHO). In his role, Gavi is focused on procurement and delivery for COVAX: coordinates the development, implementation and administration of the COVAX mechanism and Gavi COVAX AMC, and also works with its partners in the Alliance, UNICEF and WHO, as well as governments on country readiness and delivery.
The Vaccine Alliance brings together developing and donor governments, the World Health Organization, UNICEF, the World Bank, vaccine manufacturers, technical agencies, civil society, the Bill & Melinda Gates Foundation and other private sector partners. A full list of donor governments and other leading funding agencies for Gavi’s work can be found here.
+41 79 682 18 95 [email protected]
+41 79 429 3671 [email protected]
+41 79 711 55 54 [email protected]
+ 41 79 529 92 87 [email protected]
+41 79 913 94 41 [email protected]